Boehringer Ingelheim India and NIPER Raebareli Sign MoU to Strengthen Pharmaceutical Education and Research Collaboration
Feb 19, 2026
New Delhi [India], February 19: Boehringer Ingelheim India Private Limited today announced the signing of a Memorandum of Understanding (MoU) with the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, including its Centre of Excellence for Novel Drug Delivery Systems (CoE-NDDS). The MoU was signed at the Department of Pharmaceuticals in the presence of Shri Manoj Joshi, IAS, Secretary, Department of Pharmaceuticals.